Diversified strategies

Carmignac Multi Expertise

Global marketArticle 8
Share Class
A EUR AccFR0010149203
Benefit from Carmignac’s diverse expertise through a single Fund
  • A multi-strategy solution capitalising on Carmignac’s expertise across asset classes.
  • Capturing opportunities on global equity, bond and alternative investments.
  • Complementary and diversified allocation with a long-term perspective.
Key documents
Asset Allocation
Other100.0 %
Data as of:  Jun 30, 2026.
Risk Indicator

1

2

3

4

5

6

7

Lowest risk Highest risk
Recommended Minimum Investment Horizon
3 years
Cumulative Performance since launch
+ 131.7 %
+ 37.3 %
+ 9.2 %
+ 24.4 %
+ 8.6 %
From 02/01/2002
To 06/08/2026
Calendar Year Performance 2025
+ 7.8 %
+ 4.0 %
- 4.5 %
+ 5.7 %
+ 9.5 %
0.0 %
- 11.9 %
+ 5.1 %
+ 9.9 %
+ 4.7 %
Net Asset Value
€231.65
Asset Under Management
212 M €
Net Equity Exposure30/06/2026
42,9 %
SFDR - Fund Classification

Article

8
Data as of:  Aug 6, 2026.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Until 17 March 2024, the name of the fund was Carmignac Profil Reactif 50 and the reference indicator was 30% MSCI AC WORLD (USD, Reinvested Net Dividends) + 70% ICE BofA Global Broad Market Index EUR Hedged. Quarterly Rebalanced. Performances are presented using the chaining method.
Sustainable Finance Disclosure Regulation (SFDR) 2019/2088. The SFDR classification of the Funds may change over time.

The strategy in a nutshell

Discover the Fund’s main features and benefits through the words of the Fund Manager.
Fund Management Team
The strategy offers a balanced and diversified exposure to markets, benefiting from Carmignac's expertise in the equity, bond and alternative asset classes.”
View Fund's characteristics

Carmignac Multi Expertise fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  Jul 31, 2026.
Fund management team

Market environment

  • July was dominated by two themes: renewed inflation concerns and growing scrutiny of the AI investment cycle.
  • Rising energy prices and resilient macroeconomic data pushed developed market government bond yields higher. Although major central banks kept policy rates unchanged, their hawkish tone reinforced the higher-for-longer narrative. Sovereign yield curves bear steepened on both side of the Atlantic, driven by a stronger rise in long-end yields.
  • Macroeconomic data remained resilient on both sides of the Atlantic. US growth moderated while inflation surprised to the downside, whereas euro area growth exceeded expectations but inflation accelerated.
  • Early in the month, escalating US-Iran tensions briefly lifted Brent crude above USD 100/bbl, fuelling inflation concerns. As geopolitical risks eased, markets refocused on the Q2 earnings season.
  • Q2 earnings shifted investors’ focus from AI enthusiasm to AI onetization, leading to greater differentiation across the sector.
  • Hyperscalers remained relatively resilient, while semiconductor stocks and other AI beneficiaries came under pressure from stretched valuations, export control concerns and China’s technological progress.
  • Hedge fund deleveraging accelerated the sell-off in AI-related names, with the SOX falling more than 20% over the month.
  • Emerging markets underperformed due to their exposure to semiconductors, while value and quality stocks outperformed in developed markets. Credit markets also weakened, with the iTraxx Xover widening by 16bps.

Performance commentary

  • Against this backdrop, our strategy delivered positive performance in both absolute and relative terms.
  • Our equity strategies, Carmignac Portfolio Investissement and Carmignac Portfolio Grandchildren, contributed positively to performance.
  • By contrast, our fixed income portfolios and alternative strategies were somewhat disappointing over the period and detracted from performance.

Outlook strategy

  • Our macro view remains broadly constructive. Global growth continues to prove resilient, supported by strong corporate earnings and the ongoing AI investment cycle. At the same time, we believe inflation will remain structurally higher, driven by fiscal spending, deglobalisation and infrastructure investment, limiting the scope for lower long-term yields.
  • We maintain a meaningful equity exposure while gradually reducing portfolio beta. We remain constructive on AI, but with a more selective approach, favouring high-quality names across technology, financials and healthcare.
  • We used the recent semiconductor volatility to rebuild high-conviction positions at more attractive valuations, particularly in Asia, with SK Hynix re-entering our top ten holdings.
  • In fixed income, we continue to run a low-duration stance, combining negative US duration with modestly positive European duration and a curve-steepening bias. We remain cautious on credit.
  • As yields moved higher during the month, we took profits on some duration shorts, increasing overall portfolio duration to around 1.
  • In FX, we took profits on Asian currencies, particularly the KRW, while maintaining an underweight US dollar exposure. We also increased our exposure to gold mining equities, which we believe continue to offer an attractive risk-reward profile at current valuation levels.

Performance Overview

Data as of:  Aug 6, 2026.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
Until 31 December 2012, the reference indicators’ equity indices were calculated ex-dividend. Since 1 January 2013, they have been calculated with net dividends reinvested. Until 31 December 2020, the bond index was the FTSE Citigroup WGBI All Maturities Eur. Until 31 December 2021, the Fund’s reference indicator comprised 50% MSCI AC WORLD NR and 50% ICE BofA Global Government Index. Performances are presented using the chaining method.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Until 17 March 2024, the name of the fund was Carmignac Profil Reactif 50 and the reference indicator was 30% MSCI AC WORLD (USD, Reinvested Net Dividends) + 70% ICE BofA Global Broad Market Index EUR Hedged. Quarterly Rebalanced. Performances are presented using the chaining method.
Source: Carmignac at 07/08/2026

Carmignac Multi Expertise Portfolio overview

Below is an overview of the composition of the portfolio.

Asset Allocation

Data as of:  Jun 30, 2026.
Fixed Income Strategies39.3 %
Equity Strategies38.9 %
Alternative strategies20.4 %
Cash, Cash Equivalents and Derivatives Operations1.4 %
View details

Key figures

Below are the key figures for the Fund, which will give you a clearer idea of the Fund's equity and bond management and positioning.

Exposure Data

Data as of:  Jun 30, 2026.
Equity Investment Weight55.0%
Net Equity Exposure42.9%
Active Share49.9%
Modified Duration1.8
Yield to Maturity4.9%
Average RatingBBB+
Yield to Maturity (YTM) is the estimated annual rate of return expected on a bond if held until maturity and assuming all payments made as scheduled and reinvested at this rate. For perpetual bonds, the next call date is used for computation. Note that the yield shown does not take into account the FX carry and fees and expenses of the portfolio. The portfolio’s YTM is the weighted average individual bonds holdings' YTMs within the portfolio.

Articles that may interest you

Notice to shareholdersFebruary 9, 2024English

Changes to the fund - Carmignac Profil Reactif 50

3 minute(s) read
Find out more
AwardsApril 11, 2022English

Carmignac awarded across strategies in Europe

2 minute(s) read
Find out more
AwardsApril 15, 2021English

Carmignac awarded across asset classes by Lipper 2021

1 minute(s) read
Find out more
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
The Fund is a common fund in contractual form (FCP) conforming to the UCITS Directive under French law.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.